
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 16 | 1414.10 | 1416.90 | 6 |
| 62 | 1413.95 | 1416.95 | 17 |
| 10 | 1413.90 | 1417.15 | 6 |
| 6 | 1412.50 | 1417.20 | 1 |
| 45 | 1412.45 | 1417.25 | 16 |
| 6522 | Total | Total | 2349 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 16 | 1414.10 | 1416.90 | 6 |
| 62 | 1413.95 | 1416.95 | 17 |
| 10 | 1413.90 | 1417.15 | 6 |
| 6 | 1412.50 | 1417.20 | 1 |
| 45 | 1412.45 | 1417.25 | 16 |
| 6522 | Total | Total | 2349 |
| Open | 1,400.20 |
| Previous Close | 1,405.00 |
| Volume | 47,763.00 |
| Value (Lacs) | 672.31 |
| VWAP | 1,414.84 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 14,726 |
| High | 1,424.60 |
| Low | 1,400.20 |
| UC Limit | 1,686.00 |
| LC Limit | 1,124.00 |
| 52 Week High | 2,451.70 |
| 52 Week Low | 1,345.00 |
| Face Value | 1.00 |
| All Time High | 2,664.00 |
| All Time Low | 900.05 |
| 20D Avg Volume | 182,949 |
| 20D Avg Delivery(%) | 25.24 |
| Book Value Per Share | 173.27 |
| Dividend Yield | 0.76 |
| TTM EPS See historical trend | 30.97 (-2.20% YoY) |
| TTM PE See historical trend | 45.45 (Low PE) |
| P/B See historical trend | 8.13 (Low P/B) |
| Sector PE | 40.08 |
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
2 out of 3 years Concord Biotech has given positive returns in December.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| December | 10.09% (2023) | 7.00% | -0.18% | -0.18% | 4.61% |
Concord Biotech Standalone September 2025 Net Sales at Rs 247.06 crore, down 20.35% Y-o-Y Nov 27 2025 11:55 AM
Concord Biotech Shareholders Approve u20b91 Dividend, Re-appoint Director Sep 11 2025 03:04 PM
Concord Biotech Standalone June 2025 Net Sales at Rs 203.99 crore, down 5.47% Y-o-Y Aug 22 2025 12:23 PM
Stocks to Watch Today: Kotak Bank, CDSL, Balkrishna Ind, Orient Cement, Tata Chemicals, Poonawalla Fincorp, VA Tech Wabag, RITES in focus on 28 July Jul 28 2025 03:09 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 740159 | Price 2589.86 | % Traded 0.70 |
| Qty 697936 | Price 2596.08 | % Traded 0.67 |
| Qty 577183 | Price 2596.08 | % Traded 0.55 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Concord Biotech | 1,410.30 | 0.38 | 14,754.02 | 45.89 | 8.14 | 20.57 | -35.34 | 372 | 1,200 | 0.00 |
| Biocon | 388.55 | -5.23 | 51,947.72 | 107.04 | 2.47 | 4.68 | 2.33 | 1,429 | 15,261 | 0.82 |
| Sun Pharma Adv | 150.24 | -0.86 | 4,875.61 | - | - | 0.00 | -31.54 | -342 | 71 | -1.19 |
| Windlas Biotech | 776.55 | -1.18 | 1,627.60 | 24.30 | 3.45 | 11.99 | -28.76 | 60 | 759 | 0.05 |
| Softrak Venture | 2.18 | -4.80 | 98.27 | 218.00 | 2.16 | 0.78 | -14.84 | 0 | 2 | 0.00 |